Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin.
about
Macrophage activation syndrome: advances towards understanding pathogenesisPlatelet refractoriness in acquired hemophagocytic syndrome.Macrophage Activation Syndrome.Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.CD163 and inflammation: biological, diagnostic, and therapeutic aspects.Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis.Macrophage activation syndrome and cytokine-directed therapies.Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature.Hyperferritinemia and inflammation.Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab.Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature.The macrophage activation product sCD163 is associated with a less favourable metabolic profile in prepubertal children.Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis.Adult-Onset Still's Disease and Macrophage-Activating Syndrome Progressing to Lymphoma: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special SurgeryMacrophage activation syndrome: early diagnosis is key
P2860
Q28284000-DFB568A8-147C-4006-AB27-6E3D580B0D9CQ33395425-974F661B-E130-4D9B-B965-900AE34B7F97Q33426151-18AC008C-89C9-41F3-AC34-23D24D23571CQ36369924-F188940C-4F47-4EA8-BB7F-F6630DA3E0AAQ37993678-7EF2E753-ED45-49D3-9904-9508374EB125Q38035395-532D032F-AF60-415B-B70D-A934F1C182A0Q38161412-FD4847DF-B687-44A0-9F59-CB4E4FC8B8D4Q38224085-527BCE45-A0EF-4BBD-BF1D-C9E839635A90Q38267068-DCE67489-45C9-4FE3-AD17-47DBFEAB5023Q38524639-AA68F63C-F3CB-4AF3-BAE4-8272E7565787Q40199790-B51957BD-5C93-477B-9684-66EE1DE46289Q41029387-63AEE0A6-28AC-4B4F-B4DE-78DB4FF48C69Q47547112-070D09CA-CB36-49AE-BBE9-77BE576FC8FDQ47896040-E879FE59-3A37-49FE-94AF-E2C9E27C9AD4Q54571811-C858C7ED-C6A8-47F3-8670-B018B7D1D845Q56529255-D6F7BE31-5F11-4506-919E-547213B1DB57Q58781634-944C0FF9-B2CA-4BAE-9836-D56E2D833F6E
P2860
Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Macrophage activation syndrome ...... with anti-thymocyte globulin.
@en
Macrophage activation syndrome ...... with anti-thymocyte globulin.
@nl
type
label
Macrophage activation syndrome ...... with anti-thymocyte globulin.
@en
Macrophage activation syndrome ...... with anti-thymocyte globulin.
@nl
prefLabel
Macrophage activation syndrome ...... with anti-thymocyte globulin.
@en
Macrophage activation syndrome ...... with anti-thymocyte globulin.
@nl
P2093
P1433
P1476
Macrophage activation syndrome ...... with anti-thymocyte globulin.
@en
P2093
Andreea Coca
Bethany Marston
Jennifer Huggins
Kemp W Bundy
R John Looney
P356
10.1016/J.CLIM.2009.02.005
P577
2009-03-17T00:00:00Z